Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastic colorectal cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works matching IS 10837159 AND DT 2008 AND VI 13 AND IP 9
Results: 20
1
2
Untreated patients in 'CT Screening for Lung Cancer: Update 2007'.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
3
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
4
FDA report: eculizamab (Solaris®) for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
5
One in five cancer clinical trials is published: a terrible symptom -- what's the diagnosis?
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
6
Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology [corrected] [published erratum appears in ONCOLOGIST 2008 Oct;13(10):428].
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
7
FDA Report: Eculizumab (Soliris) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 993, doi. 10.1634/theoncologist.2008-0086
- By:
- Publication type:
- Article
8
Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 978, doi. 10.1634/theoncologist.2008-0056
- By:
- Publication type:
- Article
9
Neoplastic Meningitis.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 967, doi. 10.1634/theoncologist.2008-0138
- By:
- Publication type:
- Article
10
The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 954, doi. 10.1634/theoncologist.2008-0089
- By:
- Publication type:
- Article
11
Consensus Conference: Multimodality Management of Early- and Intermediate-Stage Non-Small Cell Lung Cancer.
- Published in:
- 2008
- By:
- Publication type:
- Proceeding
12
Gefitinib in Advanced Non-Small Cell Lung Cancer: Does It Deserve a Second Chance?
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 933, doi. 10.1634/theoncologist.2008-0019
- By:
- Publication type:
- Article
13
Commentary: Publishing Cancer Clinical Trial Results: A Scientific and Ethical Imperative.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
14
Commentary: Practicing on the Tip of an Information Iceberg? Evidence of Underpublication of Registered Clinical Trials in Oncology.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 925, doi. 10.1634/theoncologist.2008-0133
- By:
- Publication type:
- Article
15
One in Five Cancer Clinical Trials Is Published: A Terrible Symptom--What's the Diagnosis?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
16
Preserving the Sacred Bond: An Audit Must Be Performed.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 922, doi. 10.1634/theoncologist.2008-0179
- By:
- Publication type:
- Article
17
Untreated Patients in "CT Screening for Lung Cancer: Update 2007.".
- Published in:
- 2008
- By:
- Publication type:
- Letter
18
Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 1021, doi. 10.1634/theoncologist.2008-0003
- By:
- Publication type:
- Article
19
Effects of Aerobic Exercise Training in Anemic Cancer Patients Receiving Darbepoetin Alfa: A Randomized Controlled Trial.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 1012, doi. 10.1634/theoncologist.2008-0017
- By:
- Publication type:
- Article
20
Evolving Strategies for the Management of Hand--Foot Skin Reaction Associated with the Multitargeted Kinase Inhibitors Sorafenib and Sunitinib.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 1001, doi. 10.1634/theoncologist.2008-0131
- By:
- Publication type:
- Article